{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:15:41Z","timestamp":1765804541045,"version":"3.48.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002920","name":"University Grants Committee Research Grants Council","doi-asserted-by":"publisher","award":["AoE\/P-705\/16"],"award-info":[{"award-number":["AoE\/P-705\/16"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010428","name":"Innovation and Technology Fund","doi-asserted-by":"publisher","award":["ITS\/142\/20"],"award-info":[{"award-number":["ITS\/142\/20"]}],"id":[{"id":"10.13039\/501100010428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ymthe.2025.04.005","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T09:35:05Z","timestamp":1744018505000},"page":"3056-3072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gene delivery of SUMO1-derived peptide rescues neuronal degeneration and motor deficits in a mouse model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Zhaohui","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh Kanna","family":"Murugappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man Nga","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Yin Edwin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9758-3243","authenticated-orcid":false,"given":"Michael K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.04.005_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41531-023-00586-x","article-title":"Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson\u2019s disease patients","volume":"9","author":"L\u00f3pez-Aguirre","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.ymthe.2025.04.005_bib2","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1038\/s41467-023-43213-2","article-title":"A primate nigrostriatal atlas of neuronal vulnerability and resilience in a model of Parkinson\u2019s disease","volume":"14","author":"Tang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.04.005_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","article-title":"The \u03b1-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy","volume":"920","author":"Spillantini","year":"2000","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.ymthe.2025.04.005_bib4","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1038\/35017124","article-title":"Is there a cause-and-effect relationship between \u03b1-synuclein fibrillization and Parkinson\u2019s disease?","volume":"2","author":"Goldberg","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.04.005_bib5","doi-asserted-by":"crossref","first-page":"E4648","DOI":"10.1073\/pnas.1704698114","article-title":"Selective lowering of synapsins induced by oligomeric \u03b1-synuclein exacerbates memory deficits","volume":"114","author":"Larson","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.005_bib6","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"\u03b1-Synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils","volume":"322","author":"Lashuel","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.04.005_bib7","doi-asserted-by":"crossref","first-page":"48976","DOI":"10.1074\/jbc.M208192200","article-title":"Characterization of cytoplasmic \u03b1-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.005_bib8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1742-4658.2012.08489.x","article-title":"Role of \u03b1-synuclein penetration into the membrane in the mechanisms of oligomer pore formation","volume":"279","author":"Tsigelny","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.ymthe.2025.04.005_bib9","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1073\/pnas.1913904117","article-title":"The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration","volume":"117","author":"Mahul-Mellier","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.005_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ymthe.2025.04.005_bib11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant \u03b1-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.04.005_bib12","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/bi991447r","article-title":"Fibrils formed in vitro from \u03b1-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid","volume":"39","author":"Conway","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2025.04.005_bib13","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1021\/bi010616g","article-title":"Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human \u03b1-synuclein","volume":"40","author":"Li","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2025.04.005_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41594-020-0384-x","article-title":"A short motif in the N-terminal region of \u03b1-synuclein is critical for both aggregation and function","volume":"27","author":"Doherty","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.04.005_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.chembiol.2020.12.010","article-title":"A SUMO1-derived peptide targeting SUMO-interacting motif inhibits \u03b1-synuclein aggregation","volume":"28","author":"Liang","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ymthe.2025.04.005_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005905","article-title":"High-resolution global peptide-protein docking using fragments-based PIPER-FlexPepDock","volume":"13","author":"Alam","year":"2017","journal-title":"Plos Comput. Biol."},{"key":"10.1016\/j.ymthe.2025.04.005_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40478-017-0416-x","article-title":"AAV1\/2-induced overexpression of A53T-\u03b1-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease","volume":"5","author":"Ip","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2025.04.005_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","article-title":"Quantification of \u03b2-sheet amyloid fibril structures with thioflavin T","volume":"309","author":"LeVine","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymthe.2025.04.005_bib19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","article-title":"Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease","volume":"125","author":"Wagner","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2025.04.005_bib20","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46112","article-title":"An engineered monomer binding-protein for \u03b1-synuclein efficiently inhibits the proliferation of amyloid fibrils","volume":"8","author":"Agerschou","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2025.04.005_bib21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","article-title":"A new era for understanding amyloid structures and disease","volume":"19","author":"Iadanza","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.04.005_bib22","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.1039\/C8CC02204F","article-title":"Secondary nucleation in amyloid formation","volume":"54","author":"T\u00f6rnquist","year":"2018","journal-title":"Chem. Comm."},{"key":"10.1016\/j.ymthe.2025.04.005_bib23","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1073\/pnas.1315346111","article-title":"Solution conditions determine the relative importance of nucleation and growth processes in \u03b1-synuclein aggregation","volume":"111","author":"Buell","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.005_bib24","doi-asserted-by":"crossref","first-page":"19213","DOI":"10.1074\/jbc.M110551200","article-title":"Biochemical characterization of the core structure of \u03b1-synuclein filaments","volume":"277","author":"Miake","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.005_bib25","doi-asserted-by":"crossref","first-page":"30773","DOI":"10.1016\/S0021-9258(18)47347-4","article-title":"The Alzheimer A\u03b2 peptide develops protease resistance in association with its polymerization into fibrils","volume":"269","author":"Nordstedt","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.005_bib26","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein","volume":"149","author":"Cremades","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.04.005_bib27","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1021\/bi0121353","article-title":"Vesicle permeabilization by protofibrillar \u03b1-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism","volume":"41","author":"Volles","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2025.04.005_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/srep24526","article-title":"Structural and functional properties of prefibrillar \u03b1-synuclein oligomers","volume":"6","author":"Pieri","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.04.005_bib29","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"\u03b1-Synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"The Lancet"},{"key":"10.1016\/j.ymthe.2025.04.005_bib30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.04.005_bib31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s12035-012-8329-y","article-title":"\u03b1-Synuclein Elevation in Human Neurodegenerative Diseases: Experimental, Pathogenetic, and Therapeutic Implications","volume":"47","author":"Ulusoy","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymthe.2025.04.005_bib32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrn.2017.75","article-title":"Animal models of \u03b1-synucleinopathy for Parkinson disease drug development","volume":"18","author":"Koprich","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ymthe.2025.04.005_bib33","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.neurobiolaging.2014.11.015","article-title":"Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors","volume":"36","author":"Van der Perren","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymthe.2025.04.005_bib34","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/brain\/awl382","article-title":"Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain","volume":"130","author":"Eslamboli","year":"2007","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2025.04.005_bib35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/gt.2010.179","article-title":"Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2\/1, 2\/2, 2\/5, 2\/6.2, 2\/7, 2\/8 and 2\/9","volume":"18","author":"Van der Perren","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.04.005_bib36","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","article-title":"Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of \u03b1-synuclein in midbrain dopamine neurons","volume":"45","author":"Decressac","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2025.04.005_bib37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40478-022-01403-x","article-title":"Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies","volume":"10","author":"Koss","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2025.04.005_bib38","doi-asserted-by":"crossref","first-page":"8202","DOI":"10.1021\/bi200760h","article-title":"Designed hairpin peptides interfere with amyloidogenesis pathways: fibril formation and cytotoxicity inhibition, interception of the preamyloid state","volume":"50","author":"Huggins","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2025.04.005_bib39","doi-asserted-by":"crossref","first-page":"561462","DOI":"10.3389\/fnins.2020.561462","article-title":"Insights into peptide inhibition of \u03b1-synuclein aggregation","volume":"14","author":"Torpey","year":"2020","journal-title":"Front \u039deurosci"},{"key":"10.1016\/j.ymthe.2025.04.005_bib40","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1021\/acs.jmedchem.1c00086","article-title":"Rationally designed protein-based inhibitor of \u03b1-synuclein fibrillization in cells","volume":"64","author":"Priss","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ymthe.2025.04.005_bib41","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46775","article-title":"Inhibition of synucleinopathic seeding by rationally designed inhibitors","volume":"9","author":"Sangwan","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2025.04.005_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb5924","article-title":"Small-molecule sequestration of amyloid-\u03b2 as a drug discovery strategy for Alzheimer\u2019s disease","volume":"6","author":"Heller","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2025.04.005_bib43","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1002\/anie.201309001","article-title":"Sequestration of a \u03b2-hairpin for control of \u03b1-synuclein aggregation","volume":"53","author":"Mirecka","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ymthe.2025.04.005_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1326-5-43","volume":"5","author":"Koprich","year":"2010","journal-title":"Mol. Neurodegener."},{"author":"Delano","key":"10.1016\/j.ymthe.2025.04.005_bib45"},{"key":"10.1016\/j.ymthe.2025.04.005_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"Softwarex"},{"key":"10.1016\/j.ymthe.2025.04.005_bib47","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03d5, \u03c8 and side-chain \u03c7(1) and \u03c7(2) dihedral angles","volume":"8","author":"Best","year":"2012","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ymthe.2025.04.005_bib48","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ymthe.2025.04.005_bib49","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1800690115","article-title":"Developing a molecular dynamics force field for both folded and disordered protein states","volume":"115","author":"Robustelli","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.005_bib50","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ymthe.2025.04.005_bib51","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: A new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.ymthe.2025.04.005_bib52","doi-asserted-by":"crossref","first-page":"8345","DOI":"10.1063\/1.465608","article-title":"The effect of long-range electrostatic interactions in simulations of macromolecular crystals: A comparison of the Ewald and truncated list methods","volume":"99","author":"York","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ymthe.2025.04.005_bib53","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/(SICI)1521-3773(19990115)38:1\/2<236::AID-ANIE236>3.0.CO;2-M","article-title":"Peptide Folding: When Simulation Meets Experiment","volume":"38","author":"Daura","year":"1999","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ymthe.2025.04.005_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.ymthe.2025.04.005_bib55","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1074\/jbc.274.12.7619","article-title":"Mutant and wild type human \u03b1-synucleins assemble into elongated filaments with distinct morphologies in vitro","volume":"274","author":"Giasson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.005_bib56","first-page":"E1994","article-title":"Structural characterization of toxic oligomers that are kinetically trapped during \u03b1-synuclein fibril formation","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.005_bib57","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.04.005_bib58","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JPD-171248","article-title":"Best practices for generating and using \u03b1-synuclein pre-formed fibrils to model Parkinson\u2019s disease in rodents","volume":"8","author":"Polinski","year":"2018","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ymthe.2025.04.005_bib59","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ab.2010.02.001","article-title":"Strategies to increase the reproducibility of protein fibrillization in plate reader assays","volume":"400","author":"Giehm","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymthe.2025.04.005_bib60","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.brainres.2014.08.021","article-title":"A new Drosophila model to study the interaction between genetic and environmental factors in Parkinson's disease","volume":"1583","author":"Varga","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.ymthe.2025.04.005_bib61","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbrc.2006.05.112","article-title":"Biochemical investigation of Tau protein phosphorylation status and its solubility properties in Drosophila","volume":"346","author":"Chau","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2025.04.005_bib62","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/hmg\/ddi331","article-title":"Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway","volume":"14","author":"Berger","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.04.005_bib63","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","article-title":"A Drosophila model of Parkinson's disease","volume":"404","author":"Feany","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.04.005_bib64","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/mds.23388","article-title":"Gender differences in Parkinson's disease: clinical characteristics and cognition","volume":"25","author":"Miller","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymthe.2025.04.005_bib65","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1601-183X.2009.00552.x","article-title":"Allen Reference Atlas. A Digital Color Brain Atlas of the C57BL\/6J Male Mouse","volume":"9","author":"Goldowitz","year":"2010","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.ymthe.2025.04.005_bib66","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/2041-210X.12874","article-title":"ToxTrac: A fast and robust software for tracking organisms","volume":"9","author":"Rodriguez","year":"2018","journal-title":"Methods Ecol. Evol."},{"key":"10.1016\/j.ymthe.2025.04.005_bib67","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/ejn.12459","article-title":"Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease","volume":"39","author":"Stott","year":"2014","journal-title":"Eur. J. Neurosci."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625002795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625002795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:12:20Z","timestamp":1765804340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625002795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1525001625002795"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.04.005","relation":{},"ISSN":["1525-0016"],"issn-type":[{"type":"print","value":"1525-0016"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene delivery of SUMO1-derived peptide rescues neuronal degeneration and motor deficits in a mouse model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}